Personal Care Products

Paranovus ENT Tech

Paranovus ENT Tech released FY2026 Semi-Annual Earnings on December 5, 2025 (EST), with actual revenue of USD 12.41 M and EPS of USD -0.008

Paranovus ENT Tech released FY2026 Q1 earnings on December 5, 2025 (EST), with actual revenue of USD 6.207 M and EPS of USD -0.004

Paranovus ENT Tech released FY2026 Q2 earnings on December 5, 2025 (EST), with actual revenue of USD 6.207 M and EPS of USD -0.004

Paranovus ENT Tech released FY2025 Annual Earnings on August 4, 2025 (EST) with actual revenue of USD 71.54K and EPS of USD -0.0933

Paranovus ENT Tech released FY2025 Q4 earnings on August 4 (EST), actual revenue USD 1.544 K, actual EPS USD -0.0212

Paranovus ENT Tech released FY2025 Q3 earnings on August 4, 2025 (EST), actual revenue USD 1.544 K, actual EPS USD -0.0212

Paranovus ENT Tech released FY2025 9 Months earnings on August 4, 2025 (EST), actual revenue USD 70K, actual EPS USD -0.0921

Paranovus ENT Tech released FY2025 Q1 earnings on April 24, 2025 (EST) with actual revenue of USD 34.23 K and EPS of USD -0.0351

Paranovus ENT Tech released FY2025 Semi-Annual Earnings on April 24 (EST), actual revenue USD 68.45 K, actual EPS USD -0.0702

Paranovus ENT Tech released FY2025 Q2 earnings on April 24, 2025 (EST) with actual revenue of USD 34.23 K and EPS of USD -0.0351

Paranovus ENT Tech released FY2024 Q3 earnings on August 1, 2024 (EST), with actual revenue of USD 0 and EPS of USD -1.2486

Paranovus ENT Tech released FY2024 Annual Earnings on August 1, 2024 (EST) with actual revenue of USD 0 and EPS of USD -1.3801

Paranovus ENT Tech released FY2024 Q4 earnings on August 1, 2024 (EST) with actual revenue of USD 0 and EPS of USD -1.2486

Paranovus ENT Tech released FY2024 9 Months Earnings on August 1 (EST), with actual revenue of USD 0 and EPS of USD 0.2847

Paranovus ENT Tech released FY2024 Q1 earnings on January 12, 2024 (EST), with actual revenue of USD 0 and EPS of USD 0.7666

Paranovus ENT Tech released FY2024 Semi-Annual earnings on January 12 (EST), actual revenue USD 0, actual EPS USD 1.5333

Paranovus ENT Tech released FY2024 Q2 earnings on January 12 (EST) with actual revenue of USD 0 and EPS of USD 0.7666

Paranovus ENT Tech released FY2023 earnings on July 27 (EST), actual revenue USD 0 (forecast USD 88.87 M), actual EPS USD -12.6343 (forecast USD 9.6)

Paranovus ENT Tech released FY2023 Q4 earnings on July 27 Post-Market (EST), actual revenue USD -20.11 M, actual EPS USD -2.6254

Beasley Broadcast

A SPAC III Acquisition

NXG CUSHING MIDSTREAM ENERGY F COM 0.001(S/R 11/12/2025)

Enveric Biosciences

Mawson Infrastructure

HeartBeam

Creative Global Tech

Grande

Biodexa Pharmaceuticals

Oriental Culture

L'Oréal S.A.

Beiersdorf

Kao Corporation

ELF Beauty

Interparfums

Oddity Tech

Yatsen

Nu Skin

Natures Sunshine

USANA Health Sciences

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap